Journal of Applied Physiology Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 53: 330-334, 1982;
8750-7587/82 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huisveld, I. A.
Right arrow Articles by Bouma, B. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huisveld, I. A.
Right arrow Articles by Bouma, B. N.

Journal of Applied Physiology, Vol 53, Issue 2 330-334, Copyright © 1982 by American Physiological Society


ARTICLES

Oral contraceptives and fibrinolysis among female cyclists before and after exercise

I. A. Huisveld, A. J. Hospers, M. J. Bernink, M. W. Biersteker, W. B. Erich and B. N. Bouma

The effect of oral contraceptives on a number of plasma fibrinolytic variables and antithrombin III was studied in 20 highly trained women before and immediately after exhaustive exercise on a bicycle ergometer. Two groups were studied, 11 women using an oral contraceptive agent (OCA group) and 9 women not using an oral contraceptive (control group). Factor XII, prekallikrein, plasminogen, alpha 2-antiplasmin, and antithrombin III activities were determined in plasma as well as a number of cardiovascular, respiratory, and metabolic components. Resting values showed a significantly higher level of prekallikrein and plasminogen in the OCA group compared with the control group. Exercise plasma values of components of the fibrinolytic system were significantly higher than resting values in both groups. However, when corrected for plasma volume changes, the exercise levels of prekallikrein and antithrombin III were significantly decreased in the OCA group only, whereas alpha 2-antiplasmin exercise level was significantly lower in both groups. Our results indicate that use of OCA even with an estrogen dosage as low as 30 micrograms has an effect on resting and exercise fibrinolytic variables; an effect, however, which does not seem to interfere with maximal performance in trained women.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online